Document:

Unassociated Document

    EXHIBIT
      10.1 2007 NON-QUALIFIED STOCK COMPENSATION PLAN 

     
      

    2007
      NON-QUALIFIED STOCK COMPENSATION PLAN 

    

    1.
      Purpose
      of Plan 

    

    1.1
      This
      2007
      NON-QUALIFIED STOCK
      COMPENSATION PLAN (the “Plan”) of HouseRaising, Inc., a North Carolina
      corporation (the “Company”), for employees, directors, officers consultants,
      advisors and other persons associated with the Company, is intended to advance
      the best interests of the Company by providing those persons who have a
      substantial responsibility for its management and growth with additional
      incentive and by increasing their proprietary interest in the success of the
      Company, thereby encouraging them to maintain their relationships with the
      Company. Further, the availability and offering of stock options and common
      stock under the Plan supports and increases the Company's ability to attract
      and
      retain individuals of exceptional talent upon whom, in large measure, the
      sustained progress, growth and profitability of the Company depends.

    

    2.
      Definitions
      

    

    2.1
      For
      Plan
      purposes, except where the context might clearly indicate otherwise, the
      following terms shall have the meanings set forth below: 

    

    “Board”
      shall mean the Board of Directors of the Company. 

    

    “Committee”
      shall mean the Compensation Committee, or such other committee appointed by
      the
      Board, which shall be designated by the Board to administer the Plan, or the
      Board if no committees have been established. The Committee shall be composed
      of
two
      or
      more persons as
      from
      time to time are appointed to serve by the Board. Each member of the Committee,
      while serving as such, shall be a disinterested person with the meaning of
      Rule
      16b-3 promulgated under the Securities Exchange Act of 1934. 

    

    “Common
      Shares” shall mean the Company's Common Shares, $.001 par value per share, or,
      in the event that the outstanding Common Shares are hereafter changed into
      or
      exchanged for different shares of securities of the Company, such other shares
      or securities. 

    

    “Company”
      shall mean HouseRaising, Inc., a North Carolina corporation and any parent
      or
      subsidiary corporation of HouseRaising, Inc. as such terms are defined in
      Sections 425(e) and 425(f), respectively, of the Code. 

    

    “Fair
      Market Value” shall mean, with respect to the date a given stock option is
      granted or exercised, the average of the highest and lowest reported sales
      prices of the Common Shares, as reported by such responsible reporting service
      as the Committee may select, or if there were not transactions in the Common
      Shares on such day, then the last preceding day on which transactions took
      place. The above withstanding, the Committee may determine the Fair Market
      Value
      in such other manner as it may deem more equitable for Plan purposes or as
      is
      required by applicable laws or regulations. 

    

    “Optionee”
      shall mean an employee of the company who has been granted one or more Stock
      Options under the Plan. 

    

    “Common
      Stock” shall mean shares of common stock which are issued by the Company
      pursuant to Section 5, below. 

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

    

    “Common
      Stockholder”  
      means
      the
      employee of, consultant to, or director of the Company or other person to whom
      shares of Common Stock are issued pursuant to this Plan. 

    

    “Common
      Stock Agreement” means an agreement executed by a Common Stockholder and the
      Company as contemplated by Section 5, below, which imposes on the shares of
      Common Stock held by the Common Stockholder such restrictions as the Board
      or
      Committee deem appropriate. 

    

    “Stock
      Option” or “Non-Qualified Stock Option” or “NQSO” shall mean a stock option
      granted pursuant to the terms of the Plan. 

    

    “Stock
      Option Agreement” shall mean the agreement between the Company and the Optionee
      under which the Optionee may purchase Common Shares hereunder. 

    

    3.
      Administration
      of the Plan 

    

    3.1
      The
      Committee shall administer the Plan and accordingly, it shall have full power
      to
      grant Stock Options and Common Stock, construe and interpret the Plan, establish
      rules and regulations and perform all other acts, including the delegation
      of
      administrative responsibilities, it believes reasonable and proper.

    

    3.2
      The
      determination of those eligible to receive Stock Options and Common Stock,
      and
      the amount, type and timing of each grant and the terms and conditions of the
      respective stock option agreements and Common Stock Agreements shall rest in
      the
      sole discretion of the Committee, subject to the provisions of the Plan.

    

    3.3
      The
      Committee may cancel any Stock Options awarded under the Plan if an Optionee
      conducts himself in a manner which the Committee determines to be inimical
      to
      the best interest of the Company, as set forth more fully in paragraph 8 of
      Article 11 of the Plan. 

    

    3.4
      The
      Board, or the Committee, may correct any defect, supply any omission or
      reconcile any inconsistency in the Plan, or in any granted Stock Option, in
      the
      manner and to the extent it shall deem necessary to carry it into effect.

    

    3.5
      Any
      decision made, or action taken, by the Committee or the Board arising out of
      or
      in connection with the interpretation and administration of the Plan shall
      be
      final and conclusive. 

     
      

    3.6
      Meetings
      of the Committee shall be held at such times and places as shall be determined
      by the Committee. A majority of the members of the Committee shall constitute
      a
      quorum for the transaction of business, and the vote of a majority of those
      members present at any meeting shall decide any question brought before that
      meeting. In addition, the Committee may take any action otherwise proper under
      the Plan by the affirmative vote, taken without a meeting, of a majority of
      its
      members. 

    

    3.7
      No
      member
      of the Committee shall be liable for any act or omission of any other member
      of
      the Committee or for any act or omission on his own part, including, but not
      limited to, the exercise of any power or discretion given to him under the
      Plan,
      except those resulting from his own gross negligence or willful misconduct.
      

    

    3.8
      The
      Company, through its management, shall supply full and timely information to
      the
      Committee on all matters relating to the eligibility of Optionees, their duties
      and performance, and current information on any Optionee's death, retirement,
      disability or other termination of association with the Company, and such other
      pertinent information as the Committee may require. The Company shall furnish
      the Committee with such clerical and other assistance as is necessary in the
      performance of its duties hereunder. 

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    4.
      Shares
      Subject to the Plan 

    

    4.1
      The
      total
      number of shares of the Company available for grants of Stock Options and Common
      Stock under the Plan shall be 3,500,000 Common Shares, subject to adjustment
      in
      accordance with Article 7 of the Plan, which shares may be either authorized
      but
      unissued or reacquired Common Shares of the Company. 

    

    4.2
      If
      a
      Stock Option or portion thereof shall expire or terminate for any reason without
      having been exercised in full, the unpurchased shares covered by such NQSO
      shall
      be available for future grants of Stock Options. 

    

    5.
      Award
      of Common Stock 

    

    5.1
      The
      Board
      or Committee from time to time, in its absolute discretion, may (a) award Common
      Stock to employees of, consultants to, and directors of the Company, and such
      other persons as the Board or Committee may select, and (b) permit Holders
      of
      Options to exercise such Options prior to full vesting therein and hold the
      Common Shares issued upon exercise of the Option as Common Stock. In either
      such
      event, the owner of such Common Stock shall hold such stock subject to such
      vesting schedule as the Board or Committee may impose or such vesting schedule
      to which the Option was subject, as determined in the discretion of the Board
      or
      Committee. 

    

    5.2
      Common
      Stock shall be issued only pursuant to a Common Stock Agreement, which shall
      be
      executed by the Common Stockholder and the Company and which shall contain
      such
      terms and conditions as the Board or Committee shall determine consistent with
      this Plan, including such restrictions on transfer as are imposed by the Common
      Stock Agreement. 

     
      

    5.3
      Upon
      delivery of the shares of Common Stock to the Common Stockholder, below, the
      Common Stockholder shall have, unless otherwise provided by the Board or
      Committee, all the rights of a stockholder with respect to said shares, subject
      to the restrictions in the Common Stock Agreement, including the right to
      receive all dividends and other distributions paid or made with respect to
      the
      Common Stock. 

    

    5.4.
      Notwithstanding
      anything in this Plan or any Common Stock Agreement to the contrary, no Common
      Stockholders may sell or otherwise transfer, whether or not for value, any
      of
      the Common Stock prior to the date on which the Common Stockholder is vested
      therein. 

    

    5.5
      All
      shares of Common Stock issued under this Plan (including any shares of Common
      Stock and other securities issued with respect to the shares of Common Stock
      as
      a result of stock dividends, stock splits or similar changes in the capital
      structure of the Company) shall be subject to such restrictions as the Board
      or
      Committee shall provide, which restrictions may include, without limitation,
      restrictions concerning voting rights, transferability of the Common Stock
      and
      restrictions based on duration of employment with the Company, Company
      performance and individual performance; provided that the Board or Committee
      may, on such terms and conditions as it may determine to be appropriate, remove
      any or all of such restrictions. Common Stock may not be sold or encumbered
      until all applicable restrictions have terminated or expire. The restrictions,
      if any, imposed by the Board or Committee or the Board under this Section 5
      need
      not be identical for all Common Stock and the imposition of any restrictions
      with respect to any Common Stock shall not require the imposition of the same
      or
      any other restrictions with respect to any other Common Stock. 

    

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    5.6
      Each
      Common Stock Agreement shall provide that the Company shall have the right
      to
      repurchase from the Common Stockholder the unvested Common Stock upon a
      termination of employment, termination of directorship or termination of a
      consultancy arrangement, as applicable, at a cash price per share equal to
      the
      purchase price paid by the Common Stockholder for such Common Stock.

    

    5.7
      In
      the
      discretion of the Board or Committee, the Common Stock Agreement may provide
      that the Company shall have the a right of first refusal with respect to the
      Common Stock and a right to repurchase the vested Common Stock upon a
      termination of the Common Stockholder's employment with the Company, the
      termination of the Common Stockholder's consulting arrangement with the Company,
      the termination of the Common Stockholder's service on the Company's Board,
      or
      such other events as the Board or Committee may deem appropriate. 

    

    5.8
      The
      Board
      or Committee shall cause a legend or legends to be placed on certificates
      representing shares of Common Stock that are subject to restrictions under
      Common Stock Agreements, which legend or legends shall make appropriate
      reference to the applicable restrictions. 

    

    6.
      Stock
      Option Terms and Conditions 

    

    6.1
      Consistent
      with the Plan's purpose, Stock Options may be granted to non-employee directors
      of the Company or other persons who are performing or who have been engaged
      to
      perform services of special importance to the management, operation or
      development of the Company. 

     
      

    6.2
      All
      Stock
      Options granted under the Plan shall be evidenced by agreements, which shall
      be
      subject to applicable provisions of the Plan, and such other provisions as
      the
      Committee may adopt, including the provisions set forth in paragraphs 2 through
      11 of this Section 6. 

    

    6.3
      All
      Stock
      Options granted hereunder must be granted within ten years from the earlier
      of
      the date of this Plan is adopted or approved by the Company's shareholders.
      

    

    6.4
      No
      Stock
      Option granted to any employee or 10% Shareholder shall be exercisable after
      the
      expiration of ten years from the date such NQSO is granted. The Committee,
      in
      its discretion, may provide that an Option shall be exercisable during such
      ten-year period or during any lesser period of time. 

    

    The
      Committee may establish installment exercise terms for a Stock Option such
      that
      the NQSO becomes fully exercisable in a series of cumulating portions. If an
      Optionee shall not, in any given installment period, purchase all the Common
      Shares which such Optionee is entitled to purchase within such installment
      period, such Optionee's right to purchase any Common Shares not purchased in
      such installment period shall continue until the expiration or sooner
      termination of such NQSO. The Committee may also accelerate the exercise of
      any
      NQSO. However, no NQSO, or any portion thereof, may be exercisable until thirty
      (30) days following date of grant (“30-Day Holding Period.”). 

    

    6.5
      A
      Stock
      Option, or portion thereof, shall be exercised by delivery of (i) a written
      notice of exercise of the Company specifying the number of common shares to
      be
      purchased, and (ii) payment of the full price of such Common Shares, as fully
      set forth in paragraph 6 of this Section 6. 

    

    No
      NQSO
      or installment thereof shall be exercisable except with respect to whole shares,
      and fractional share interests shall be disregarded. Not less than 100 Common
      Shares may be purchased at one time unless the number purchased is the total
      number at the time available for purchase under the NQSO. Until the Common
      Shares represented by an exercised NQSO are issued to an Optionee, he shall
      have
      none of the rights of a shareholder. 

    

    6.6 The
      exercise price of a Stock Option, or portion thereof, may be paid: 

    

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    A.
      In
      United
      States dollars, in cash or by cashier's check, certified check, bank draft
      or
      money order, payable to the order of the Company in an amount equal to the
      option price; or 

    

    B.
      At
      the
      discretion of the Committee, through the delivery of fully paid and
      nonassessable Common Shares, with an aggregate Fair Market Value on the date
      the
      NQSO is exercised equal to the option price, provided such tendered Shares
      have
      been owned by the Optionee for at least one year prior to such exercise; or
      

     
      

    C.
      By
      a
      combination of both A and B above. 

    

    The
      Committee shall determine acceptable methods for tendering Common Shares as
      payment upon exercise of a Stock Option and may impose such limitations and
      prohibitions on the use of Common Shares to exercise an NQSO as it deems
      appropriate. 

    

    6.7
      With
      the
      Optionee's consent, the Committee may cancel any Stock Option issued under
      this
      Plan and issue a new NQSO to such Optionee. 

    

    6.8
      Except
      by
      will or the laws of descent and distribution, no right or interest in any Stock
      Option granted under the Plan shall be assignable or transferable, and no right
      or interest of any Optionee shall be liable for, or subject to, any lien,
      obligation or liability of the Optionee. Stock Options shall be exercisable
      during the Optionee's lifetime only by the Optionee or the duly appointed legal
      representative of an incompetent Optionee. 

    

    6.9
      If
      the
      Optionee shall die while associated with the Company or within three months
      after termination of such association, the personal representative or
      administrator of the Optionee's estate or the person(s) to whom an NQSO granted
      hereunder shall have been validly transferred by such personal representative
      or
      administrator pursuant to the Optionee's will or the laws of descent and
      distribution, shall have the right to exercise the NQSO for one year after
      the
      date of the Optionee's death, to the extent (i) such NQSO was exercisable on
      the
      date of such termination of employment by death, and (ii) such NQSO was not
      exercised, and (iii) the exercise period may not be extended beyond the
      expiration of the term of the Option. 

    

    No
      transfer of a Stock Option by the will of an Optionee or by the laws of descent
      and distribution shall be effective to bind the Company unless the Company
      shall
      have been furnished with written notice thereof and an authenticated copy of
      the
      will and/or such other evidence as the Committee may deem necessary to establish
      the validity of the transfer and the acceptance by the transferee or transferee
      of the terms and conditions by such Stock Option. 

    

    In
      the
      event of death following termination of the Optionee's association with the
      Company while any portion of an NQSO remains exercisable, the Committee, in
      its
      discretion, may provide for an extension of the exercise period of up to one
      year after the Optionee's death but not beyond the expiration of the term of
      the
      Stock Option. 

    

    6.10
      Any
      Optionee who disposes of Common Shares acquired on the exercise of a NQSO by
      sale or exchange either (i) within two years after the date of the grant of
      the
      NQSO under which the stock was acquired, or (ii) within one year after the
      acquisition of such Shares, shall notify the Company of such disposition and
      of
      the amount realized upon such disposition. The transfer of Common Shares may
      also be Common by applicable provisions of the Securities Act of 1933, as
      amended. 

    

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    

    7.
      Adjustments
      or Changes in Capitalization 

    

    7.1
      In
      the
      event that the outstanding Common Shares of the Company are hereafter changed
      into or exchanged for a different number or kind of shares or other securities
      of the Company by reason of merger, consolidation, other reorganization,
      recapitalization, reclassification, combination of shares, stock split-up or
      stock dividend: 

     
      

    A.
      Prompt,
      proportionate, equitable, lawful and adequate adjustment shall be made of the
      aggregate number and kind of shares subject to Stock Options which may be
      granted under the Plan, such that the Optionee shall have the right to purchase
      such Common Shares as may be issued in exchange for the Common Shares
      purchasable on exercise of the NQSO had such merger, consolidation, other
      reorganization, recapitalization, reclassification, combination of shares,
      stock
      split-up or stock dividend not taken place; 

    

    B.
      Rights
      under unexercised Stock Options or portions thereof granted prior to any such
      change, both as to the number or kind of shares and the exercise price per
      share, shall be adjusted appropriately, provided that such adjustments shall
      be
      made without change in the total exercise price applicable to the unexercised
      portion of such NQSO's but by an adjustment in the price for each share covered
      by such NQSO's; or 

    

    C.
      Upon
      any
      dissolution or liquidation of the Company or any merger or combination in which
      the Company is not a surviving corporation, each outstanding Stock Option
      granted hereunder shall terminate, but the Optionee shall have the right,
      immediately prior to such dissolution, liquidation, merger or combination,
      to
      exercise his NQSO in whole or in part, to the extent that it shall not have
      been
      exercised, without regard to any installment exercise provisions in such NQSO.
      

    

    7.2
      The
      foregoing adjustments and the manner of application of the foregoing provisions
      shall be determined solely by the Committee, whose determination as to what
      adjustments shall be made and the extent thereof, shall be final, binding and
      conclusive. No fractional Shares shall be issued under the Plan on account
      of
      any such adjustments. 

    

    8.
      Merger,
      Consolidation or Tender Offer 

    

    8.1
      If
      the
      Company shall be a party to a binding agreement to any merger, consolidation
      or
      reorganization or sale of substantially all the assets of the Company, each
      outstanding Stock Option shall pertain and apply to the securities and/or
      property which a shareholder of the number of Common Shares of the Company
      subject to the NQSO would be entitled to receive pursuant to such merger,
      consolidation or reorganization or sale of assets. 

    

    8.2
      In
      the
      event that: 

    

    A.
      Any
      person other than the Company shall acquire more than 20% of the Common Shares
      of the Company through a tender offer, exchange offer or otherwise;

    

    B.
      A
      change
      in the “control” of the Company occurs, as such term is defined in Rule 405
      under the Securities Act of 1933; 

    

    C.
      There
      shall be a sale of all or substantially all of the assets of the Company;

    any
      then
      outstanding Stock Option held by an Optionee, who is deemed by the Committee
      to
      be a statutory officer (“Insider”) for purposes of Section 16 of the Securities
      Exchange Act of 1934 shall be entitled to receive, subject to any action by
      the
      Committee revoking such an entitlement as provided for below, in lieu of
      exercise of such Stock Option, to the extent that it is then exercisable, a
      cash
      payment in an amount equal to the difference between the aggregate exercise
      price of such NQSO, or portion thereof, and, (i) in the event of an offer or
      similar event, the final offer price per share paid for Common Shares, or such
      lower price as the Committee may determine to conform an option to preserve
      its
      Stock Option status, times the number of Common Shares covered by the NQSO
      or
      portion thereof, or (ii) in the case of an event covered by B or C above, the
      aggregate Fair Market Value of the Common Shares covered by the Stock Option,
      as
      determined by the Committee at such time. 

    

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    8.3
      Any
      payment which the Company is required to make pursuant to paragraph 8.2 of
      this
      Section 8 shall be made within 15 business days, following the event which
      results in the Optionee's right to such payment. In the event of a tender offer
      in which fewer than all the shares which are validly tendered in compliance
      with
      such offer are purchased or exchanged, then only that portion of the shares
      covered by an NQSO as results from multiplying such shares by a fraction, the
      numerator of which is the number of Common Shares acquired pursuant to the
      offer
      and the denominator of which is the number of Common Shares tendered in
      compliance with such offer shall be used to determine the payment thereupon.
      To
      the extent that all or any portion of a Stock Option shall be affected by this
      provision, all or such portion of the NQSO shall be terminated. 

    

    8.4
      Notwithstanding
      paragraphs 8.1 and 8.3 of this Section 8, the Committee may, by unanimous vote
      and resolution, unilaterally revoke the benefits of the above provisions;
      provided, however, that such vote is taken no later than ten business days
      following public announcement of the intent of an offer or the change of
      control, whichever occurs earlier. 

    

    9.
      Amendment
      and Termination of Plan 

    

    9.1
      The
      Board
      may at any time, and from time to time, suspend or terminate the Plan in whole
      or in part or amend it from time to time in such respects as the Board may
      deem
      appropriate and in the best interest of the Company. 

    

    9.2
      No
      amendment, suspension or termination of this Plan shall, without the Optionee's
      consent, alter or impair any of the rights or obligations under any Stock Option
      theretofore granted to him under the Plan. 

    

    9.3
      The
      Board
      may amend the Plan, subject to the limitations cited above, in such manner
      as it
      deems necessary to permit the granting of Stock Options meeting the requirements
      of future amendments or issued regulations, if any, to the Code. The original
      2004 Non-Qualified Stock Compensation Plan was filed with the Commission on
      September 28, 2004 and is amended hereby. 

    

    9.4
      No
      NQSO
      may be granted during any suspension of the Plan or after termination of the
      Plan. 

    

    10.
      Government
      and Other Regulations 

    

    10.1
      The
      obligation of the Company to issue, transfer and deliver Common Shares for
      Stock
      Options exercised under the Plan shall be subject to all applicable laws,
      regulations, rules, orders and approval which shall then be in effect and
      required by the relevant stock exchanges on which the Common Shares are traded
      and by government entities as set forth below or as the Committee in its sole
      discretion shall deem necessary or advisable. Specifically, in connection with
      the Securities Act of 1933, as amended, upon exercise of any Stock Option,
      the
      Company shall not be required to issue Common Shares unless the Committee has
      received evidence satisfactory to it to the effect that the Optionee will not
      transfer such shares except pursuant to a registration statement in effect
      under
      such Act or unless an opinion of counsel satisfactory to the Company has been
      received by the Company to the effect that such registration is not required.
      Any determination in this connection by the Committee shall be final, binding
      and conclusive. The Company may, but shall in no event be obligated to, take
      any
      other affirmative action in order to cause the exercise of a Stock Option or
      the
      issuance of Common Shares pursuant thereto to comply with any law or regulation
      of any government authority. 

    

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    11.
      Miscellaneous
      Provisions 

    

    11.1
      No
      person
      shall have any claim or right to be granted a Stock Option or Common Stock
      under
      the Plan, and the grant of an NQSO or Common Stock under the Plan shall not
      be
      construed as giving an Optionee or Common Stockholder the right to be retained
      by the Company. Furthermore, the Company expressly reserves the right at any
      time to terminate its relationship with an Optionee with or without cause,
      free
      from any liability, or any claim under the Plan, except as provided herein,
      in
      an option agreement, or in any agreement between the Company and the Optionee.
      

    

    11.2
      Any
      expenses of administering this Plan shall be borne by the Company. 

    

    11.3
      The
      payment received from Optionee from the exercise of Stock Options under the
      Plan
      shall be used for the general corporate purposes of the Company. 

    

    11.4
      The
      place
      of administration of the Plan shall be in the State of North Carolina, and
      the
      validity, construction, interpretation, administration and effect of the Plan
      and of its rules and regulations, and rights relating to the Plan, shall be
      determined solely in accordance with the laws of the State of North Carolina.
      

    

    11.5
      Without
      amending the Plan, grants may be made to persons who are foreign nationals
      or
      employed outside the United States, or both, on such terms and conditions,
      consistent with the Plan's purpose, different from those specified in the Plan
      as may, in the judgment of the Committee, be necessary or desirable to create
      equitable opportunities given differences in tax laws in other countries.

     
      

    11.6
      In
      addition to such other rights of indemnification as they may have as members
      of
      the Board or the Committee, the members of the Committee shall be indemnified
      by
      the Company against all costs and expenses reasonably incurred by them in
      connection with any action, suit or proceeding to which they or any of them
      may
      be party by reason of any action taken or failure to act under or in connection
      with the Plan or any Stock Option granted thereunder, and against all amounts
      paid by them in settlement thereof (provided such settlement is approved by
      independent legal counsel selected by the Company) or paid by them in
      satisfaction of a judgment in any such action, suit or proceeding, except a
      judgment based upon a finding of bad faith; provided that upon the institution
      of any such action, suit or proceeding a Committee member shall, in writing,
      give the Company notice thereof and an opportunity, at its own expense, to
      handle and defend the same, with counsel acceptable to the Optionee, before
      such
      Committee member undertakes to handle and defend it on his own behalf.

    

    11.7
      Stock
      Options may be granted under this Plan from time to time, in substitution for
      stock options held by employees of other corporations who are about to become
      employees of the Company as the result of a merger or consolidation of the
      employing corporation with the Company or the acquisition by the Company of
      the
      assets of the employing corporation or the acquisition by the Company of stock
      of the employing corporation as a result of which it becomes a subsidiary of
      the
      Company. The terms and conditions of such substitute stock options so granted
      may vary from the terms and conditions set forth in this Plan to such extent
      as
      the Board of Directors of the Company at the time of grant may deem appropriate
      to conform, in whole or in part, to the provisions of the stock options in
      substitution for which they are granted, but no such variations shall be such
      as
      to affect the status of any such substitute stock options as a stock option
      under Section 422A of the Code. 

    

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    11.8
       
      Notwithstanding
      anything to the contrary in the Plan, if the Committee finds by a majority
      vote,
      after full consideration of the facts presented on behalf of both the Company
      and the Optionee, that the Optionee has been engaged in fraud, embezzlement,
      theft, insider trading in the Company's stock, commission of a felony or proven
      dishonesty in the course of his association with the Company or any subsidiary
      corporation which damaged the Company or any subsidiary corporation, or for
      disclosing trade secrets of the Company or any subsidiary corporation, the
      Optionee shall forfeit all unexercised Stock Options and all exercised NQSO's
      under which the Company has not yet delivered the certificates and which have
      been earlier granted to the Optionee by the Committee. The decision of the
      Committee as to the cause of an Optionee's discharge and the damage done to
      the
      Company shall be final. No decision of the Committee, however, shall affect
      the
      finality of the discharge of such Optionee by the Company or any subsidiary
      corporation in any manner. 

    

    12.
      Written
      Agreement 

    

    12.1
      Each
      Stock Option granted hereunder shall be embodied in a written Stock Option
      Agreement which shall be subject to the terms and conditions prescribed above
      and shall be signed by the Optionee and by the Chief Executive Officer,
      President or any Executive Officer of the Company, for and in the name and
      on
      behalf of the Company. Such Stock Option Agreement shall contain such other
      provisions as the Committee, in its discretion shall deem advisable.

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    Number
      of
      Shares: __________________      
      

    Date
      of
      Grant:                                     

     

    FORM
      OF NON-QUALIFIED STOCK OPTION AGREEMENT

    

    AGREEMENT
      made this _____ day
      of
      _______________________________________ 200
       
      ,
      between
      __________________________________________________ (the
      “Optionee”), and HouseRaising, Inc., (the “Company”). 

    

    1.
      Grant
      of Option 

    

    The
      Company, pursuant to the provisions of the 2007 Non-Qualified Stock Compensation
      Plan (the “Plan”), adopted by the Board of Directors on __________________,
      the
      Company hereby grants to the Optionee, subject to the terms and conditions
      set
      forth or incorporated herein, an option to purchase from the Company all or
      any
      part of an aggregate of  _________________ shares
      of
      its $.001 par value common stock, as such common stock is now constituted,
      at
      the purchase price of $ _______ per
      share. The provisions of the Plan governing the terms and conditions of the
      Option granted hereby are incorporated in full herein by reference.

    

    2.
      Exercise
      

    

    The
      Option evidenced hereby shall be exercisable in whole or in part on or
      after  ____________________ and
      on or
      before ______________________________________,
      provided that the cumulative number of shares of common stock as to which this
      Option may be exercised (except in the event of death, retirement, or permanent
      and total disability, as provided in paragraph 6.9 of the Plan) shall not exceed
      the following amounts: 

     
      

    
      	
               
                Cumulative
                

              Number
                

              of
                Shares 

            	 	
              Prior
                to Date 

              (Note
                Inclusive of) 

            

    

       
      

    The
      Option evidenced hereby shall be exercisable by the delivery to and receipt
      by
      the Company of (i) written notice of election to exercise, in the form set
      forth
      in Attachment B hereto, specifying the number of shares to be purchased; (ii)
      accompanied by payment of the full purchase price thereof in cash or certified
      check payable to the order of the Company, or by fully paid and nonassessable
      common stock of the Company properly endorsed over to the Company, or by a
      combination thereof, and (iii) by return of this Stock Option Agreement for
      endorsement of exercise by the Company on Schedule I hereof. In the event fully
      paid and nonassessable common stock is submitted as whole or partial payment
      for
      shares to be purchased hereunder, such common stock will be valued at their
      Fair
      Market Value (as defined in the Plan) on the date such shares received by the
      Company are applied to payment of the exercise price. 

     
      

    3.
      Transferability
      

    

    The
      Option evidenced hereby is not assignable or transferable by the Optionee other
      than by the Optionee's will or by the laws of descent and distribution, as
      provided in paragraph 6.9 of the Plan. The Option shall be exercisable only
      by
      the Optionee during his lifetime. 

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    
      	
               

            	 	
              HouseRaising,
                Inc.  

            
	 	 	 
	
               

            	 	
              By:
                

            
	 	 	
              Name:
                

            
	
              ATTEST:
                

            	 	
              Title:
                

            
	 	 	 
	
              /s/
                

            	 	 
	 	 	 
	
              Secretary
                

            	 	 

    

    

    Optionee
      hereby acknowledges receipt of a copy of the Plan, attached hereto and accepts
      this Option subject to each and every term and provision of such Plan. Optionee
      hereby agrees to accept as binding, conclusive and final, all decisions or
      interpretations of the Board of Directors administering the Plan on any
      questions arising under such Plan. Optionee recognizes that if Optionee's
      employment with the Company or any subsidiary thereof shall be terminated
      without cause, or by the Optionee, prior to completion or satisfactory
      performance by Optionee (except as otherwise provided in paragraph 6 of the
      Plan) all of the Optionee's rights hereunder shall thereupon terminate; and
      that, pursuant to paragraph 6 of the Plan, this Option may not be exercised
      while there is outstanding to Optionee any unexercised Stock Option granted
      to
      Optionee before the date of grant of this Option. 

    

    
      	
              Dated: 
                __________                
                  

            	 	 
	 	 	 
	
               

            	
              Optionee
                

            	 
	 	 	 
	 	 	 
	
               

            	
              Print
                Name 

            	 
	 	 	 
	 	 	 
	
               

            	
              Address
                

            	 
	 	 	 
	 	 	 
	
               

            	
              Social
                Security No. 

            	 

    

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    ATTACHMENT
      B 

    

    NOTICE
      OF
      EXERCISE 

     

    To:
      HouseRaising,
      Inc. 

     

    (1)
      The
      undersigned hereby elects to purchase ________ shares of Common Shares (the
      “Common Shares”), of HouseRaising, Inc. , pursuant to the terms of the attached
      2007 Non-Qualified Stock Compensation Plan, and tenders herewith payment of
      the
      exercise price in full, together with all applicable transfer taxes, if any.
      

     
      

    (2)
      Please
      issue a certificate or certificates representing said shares of Common Shares
      in
      the name of the undersigned or in such other name as is specified below:

     
      

    
      	__________________
	
              (Name)

            
	 
	__________________
	
              (Address)

            
	 
	__________________ 
	
              (Address)

            

    

     

    
      	
              Dated:

            	 
	 	
              _________________________________

            
	 	
              Signature

            
	 	 
	
              Optionee: _________________________________________                    

            	
              Date
                of
                Grant: ____________________________

            

    

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    SCHEDULE
      I 

     
      

    
      	
              DATE
                

            	
              SHARES
                

              PURCHASED
                

            	
              PAYMENT
                

              RECEIVED
                

            	
              UNEXERCISED
                

              SHARES
                

              REMAINING
                

            	
              ISSUING
                

              OFFICER
                

              INITIALS
                

            
	
               

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            
	
               
                

            	
               
                

            	
               
                

            	
               
                

            	
               
                

            

    

       
      

    
      
        
        

      

      
        13EXCLUSIVE
      LICENSE AGREEMENT

    

    

    THIS
      EXCLUSIVE LICENSE AGREEMENT (the “Agreement”)
      is
      made this 6th day of February 2007, by and between Lumonall Canada Inc., a
      Canadian corporation (the “Licensor”),
      with
      its principal place of business at _________________________________, and
      Midland International Corporation (the “Licensee”)
      with
      its principal place of business at 12650
      Jane Street, King City, Ontario, Canada L7B 1A3, who hereby agree as
      follows:

    

    RECITALS:

    

    A. Licensor
      is the assignee of certain intellectual property rights (“Intellectual
      Property Rights”)
      for
      the pigments and production of the foil used in the manufacturing of photo
      luminous material (“PLM”)
      (the
“Licensed
      Materials”),
      including the exclusive rights to use the Intellectual Property Rights in the
      United States, to manufacture goods utilizing the Licensed Materials in North
      America, as well as to distribute all goods derived from the Licensed Materials
      in Canada to all non-governmental entities (the “Licensed
      Territory”).

    

    B. Licensee
      wishes to acquire from Licensor a perpetual exclusive license to Licensor’s
      Intellectual Property Rights to the Licensed Materials in the Licensed Territory
      and Licensor wishes to assign the same to Licensee pursuant to the terms and
      conditions contained herein.

    

    NOW,
      THEREFORE, in exchange for good and valuable consideration, the sufficiency
      of
      which is acknowledged, the parties agree as follows:

    

    

    ARTICLE
      I

    Exclusive
      License Grant

    

    1.1 License
      Grant.
      Subject
      to the terms and conditions of this Agreement, Licensor hereby grants to
      Licensee, and Licensee hereby accepts an irrevocable, perpetual license to
      the
      Licensed Materials for use in the Licensed Territory (the “License”),
      to
      use the Licensed Materials in the United States to manufacture goods utilizing
      the Licensed Materials in North America, as well as to distribute all goods
      derived from the Licensed Materials in Canada to all non-governmental entities
      in the Licensed Territory, including but not limited to sublicensing,
      development, manufacturing, distribution, marketing, customizing, modifying,
      and
      adding to the Licensed Materials, creation of documentation for the Licensed
      Materials, and any and all additional commercialization of the Licensed
      Materials (the “Permitted
      Purposes”).

    

    As
      used
      in this Agreement, the term “Intellectual
      Property Rights”
shall
      mean any and all rights to use the Licensed Materials existing from time to
      time
      in any jurisdiction under patent law, copyright law, moral rights law, trade
      secret law, trademark law, unfair competition law or other similar rights unless
      mutually agreed upon.

     

    
      
         

      

      
        1
          of
          15

        
          

        

      

      
         

      

    

     

    1.2 No
      Other Rights Granted.
      Apart
      from the rights afforded Licensee under this Agreement (the “License
      Rights”)
      enumerated in this Agreement, the License does not include a grant to Licensee
      of any right to engage in any other activity, nor grant any ownership right,
      title or interest, or any security interest or other interest in any
      Intellectual Property Rights relating to the Licensed Materials.

    

    1.3 Licensed
      Materials as Confidential Information.
      The
      Licensed Materials shall be deemed Confidential Information and use in
      disclosure is subject to the provisions of Article IX.

    

    1.4 Authorized
      Licensee Delegates.
      Licensee may delegate the exercise of License Rights under this Agreement to
      one
      or more persons (the “Authorized
      Licensee Delegates”)
      in the
      Licensed Territory without prior written notice to Licensor. 

    

    
      	 	
              1.4.1

            	
              The
                Licensed Rights exercisable by any Authorized Licensee Delegate shall
                be
                solely for the benefit of Licensee and shall be in strict accordance
                with
                the applicable provisions of this
                Agreement.

            

    

    

    
      	 	
              1.4.2

            	
              Prior
                to any exercise of License Rights, each Authorized Licensee Delegate
                that
                is not a wholly owned subsidiary of Licensee or of which Licensee
                is not a
                wholly owned subsidiary shall agree in writing and be bound by this
                Agreement to the same extent that the Authorized Licensee Delegate
                would
                be bound if it were an employee of
                Licensee.

            

    

    

    
      	 	
              1.4.3

            	
              Licensee
                shall be responsible to Licensor for performance of all the obligations
                under this Agreement assumed by any Authorized Licensee
                Delegate.

            

    

    

    1.5 Modifications
      of and Additions to Licensed Materials.
      The
      parties acknowledge that Licensee may amend, modify, supplement, and add to
      the
      Licensed Materials (such new materials are referred to as the “Licensee
      Additions”).
      All
      Licensee Additions shall be and remain the sole property of the Licensee.
      Licensee grants to Licensor a non-exclusive license (the “Additional
      License”)
      to use
      the Licensee Additions, provided, however, that Licensor may not use the
      Licensee Additions for any of the Permitted Purposes granted to Licensee herein,
      or otherwise compete with Licensee. 

    

    

    ARTICLE
      II

    Term
      and Termination of License

    

    2.1 Term
      of License.
      The
      License shall be in effect for a perpetual license term, unless sooner
      terminated in accordance with this Article II.

    

    2.2 Mutual
      Termination of License.
      The
      parties may terminate the License or any License Rights by mutual consent upon
      such terms as they may agree in writing.

     

    
      
         

      

      
        2
          of
          15

        
          

        

      

      
         

      

    

     

    2.3 Termination
      for Breach.
      This
      Agreement may be terminated upon the material breach of its terms and
      representations. For purposes of this Agreement, the term “material breach”
shall mean any violation by a party of a covenant or warranty or a
      misrepresentation made under this Agreement which is shown to affect adversely
      (a) the rights and benefits of the other party under this Agreement; or (b)
      the
      ability of the other party to perform its obligations under this Agreement
      to
      such a degree that a reasonable person in the management of his or her own
      affairs would be more likely than not to decline to enter into this Agreement
      in
      view of the breach. In the event of any such breach:

    

    
      	 	
              2.3.1

            	
              The
                party not in breach (the “Non-Breaching
                Party”)
                shall give the party in breach (the “Breaching
                Party”)
                notice describing the breach.

            

    

    

    
      	 	
              2.3.2

            	
              The
                Breaching Party shall have thirty (30) days from such notice to cure
                such
                breach or, if such breach cannot reasonably be cured within such
                30-day
                period, to commence actions reasonably adequate to alleviate any
                damage to
                the Non-Breaching Party resulting from the breach and to prevent
                a similar
                future breach.

            

    

    

    2.4 Other
      Terminations.
      The
      License shall terminate automatically to the extent permitted by applicable
      law
      in pertinent jurisdictions in any of the following events:

    

    
      	 	
              2.4.1

            	
              If
                Licensee becomes insolvent or admits a general inability to pay its
                debts
                as they become due, then the License shall immediately terminate
                without
                notice.

            

    

    

    
      	 	
              2.4.2

            	
              If
                Licensor becomes insolvent or admits a general inability to pay its
                debts
                as they become due, then the Licensed Materials shall immediately
                become
                the property of Licensee with full rights to perfect any and all
                rights to
                the Licensed Materials under the laws of the United States and any
                other
                jurisdiction in the Licensed
                Territory.

            

    

    

    
      	 	
              2.4.3

            	
              Either
                party may terminate the License immediately upon the discovery of
                any
                material false statement or misrepresentation contained in this
                Agreement.

            

    

    

    

    ARTICLE
      III

    Consideration
      for License

    

    3.1 Consideration
      for License Fee.
      In
      consideration for the granting of the exclusive License herein, Licensee hereby
      grants to Licensor the following:

    

    
      	 	
              3.1.1

            	
              A
                sign royalty of $2.00 (CN) per sign manufactured and sold by Licensee
                utilizing the Licensed Materials, not to exceed an aggregate of $1,000,000
                (CN); and

            

    

     

    
      
         

      

      
        3
          of
          15

        
          

        

      

      
         

      

    

     

    
      	 	
              3.1.2

            	
              A
                non-sign royalty equal to 1% of all net sales of all non-sign photo
                luminous products manufactured and sold by Licensee utilizing the
                Licensed
                Materials. For purposes herein, the term “net sales” id hereby defined as
                gross revenues, minus returns and early paid discounts, but shall
                not
                include cost of sales or Licensee’s operating expenses or general and
                administrative expense; and

            

    

    

    
      	 	
              3.1.3

            	
              An
                additional royalty not to exceed $500,000 (CN) from future profits
                derived
                by Licensee, payable as 15% of earnings before interest, taxes,
                depreciation and amortization (“EBITDA”) and payable quarterly in arrears.
                As part of Licensee’s obligation herein, Licensee agrees to issue to
                Licensor a $100,000 (CN) promissory note in the form attached hereto
                as
                Exhibit “A”, which note shall be unsecured, non-interest bearing and
                repayable in four installment payments of $25,000 per payment, due
                on or
                before May 31, 2007, August 31, 2007, November 30, 2007 and February
                28,
                2008.

            

    

    

    

    ARTICLE
      IV

    Representations

    

    4.1 Representations
      of Licensor.
      Licensor
      hereby represents and warrants to Licensee as follows:

    

    
      	 	
              4.1.1

            	
              Licensor
                has full corporate power and authority to: (i) execute, deliver and
                perform this Agreement, and (ii) carry out Licensor's obligations
                hereunder and to consummate the transactions contemplated hereby.
                The
                execution and delivery of this Agreement and the consummation by
                Licensor
                of the transactions contemplated hereby have been duly and validly
                authorized by all necessary corporate action on the part of Licensor
                (including the approval by its Board of Directors), and no other
                corporate
                proceedings on the part of Licensor are necessary to authorize this
                Agreement or to consummate the transactions contemplated hereby.
                This
                Agreement has been duly and validly executed and delivered by Licensor
                and
                constitutes the legal and binding obligation of Licensor, enforceable
                against Licensor in accordance with its terms, except as may be limited
                by
                bankruptcy, insolvency, reorganization or other similar laws affecting
                the
                enforcement of creditors' rights generally and by general principles
                of
                equity and public policy.

            

    

    

    
      	 	
              4.1.2

            	
              To
                the best of Licensor's information, knowledge and belief, the execution
                and delivery of this Agreement will
                not:

            

    

    

    (a) violate
      any of the terms and provisions of the Articles of Incorporation or bylaws
      of
      the Licensor, or any order, decree, statute, bylaw, regulation, covenant, or
      restriction applicable to the Licensor or the Licensed Materials;

     

    
      
         

      

      
        4
          of
          15

        
          

        

      

      
         

      

    

     

    (b) result
      in
      any fees, duties, taxes, assessments or other amounts relating to any of the
      Licensed Materials becoming due or payable.

    

    
      	 	
              4.1.3

            	
              The
                Licensor owns and possesses and has a good and marketable title to
                the
                Licensed Materials, free and clear of all mortgages, liens, charges,
                pledges, security interests, encumbrances or other claims whatsoever,
                whether secured or unsecured and whether arising by reason of statute
                or
                otherwise howsoever.

            

    

    

    
      	 	
              4.1.4

            	
              There
                is no litigation or administrative or governmental proceeding or
                inquiry
                pending, or to the knowledge of the Licensor, threatened against
                or
                relating to the Licensor, the Licensor's Business, or any of the
                Licensed
                Materials, nor does the Licensor know of or have reasonable grounds
                for
                believing that there is any basis for any such action, proceeding
                or
                inquiry.

            

    

    

    
      	 	
              4.1.5

            	
              None
                of the representations, warranties or covenants of the Licensor herein
                contain any untrue statement of a material fact or omit to state
                a
                material fact necessary to make the statements contained therein
                not
                misleading and all of the representations and warranties of the Licensor
                shall be true as at and as if made at the time of
                closing.

            

    

    

    4.2 Representations
      of Licensee.
      Licensee
      hereby represents and warrants to Licensee as follows:

    

    
      	 	
              4.2.1

            	
              Licensee
                is a corporation duly incorporated, validly existing and in good
                standing
                under the laws of the State of Nevada and has the requisite corporate
                power and authority to own, lease and operate its assets and properties
                and to carry on its business as it is now being or currently planned
                by
                Licensee to be conducted. Licensee is in possession of all approvals
                necessary to own, lease and operate the properties it purports to
                own,
                operate or lease and to carry on its business as it is now being
                or
                currently planned by Licensee to be conducted, except where the failure
                to
                have such approvals could not, individually or in the aggregate,
                reasonably be expected to have a material adverse effect on Licensee.
                

            

    

    

    
      	 	
              4.2.2

            	
              Licensee
                has full corporate power and authority to: (i) execute, deliver and
                perform this Agreement, and (ii) carry out Licensee's obligations
                hereunder and to consummate the transactions contemplated hereby.
                The
                execution and delivery of this Agreement and the consummation by
                Licensee
                of the transactions contemplated hereby have been duly and validly
                authorized by all necessary corporate action on the part of Licensee
                (including the approval by its Board of Directors), and no other
                corporate
                proceedings on the part of Licensee are necessary to authorize this
                Agreement or to consummate the transactions contemplated hereby.
                This
                Agreement has been duly and validly executed and delivered by Licensee
                and
                constitutes the legal and binding obligation of Licensee, enforceable
                against Licensee in accordance with its terms, except as may be limited
                by
                bankruptcy, insolvency, reorganization or other similar laws affecting
                the
                enforcement of creditors' rights generally and by general principles
                of
                equity and public policy.

            

    

     

    
      
         

      

      
        5
          of
          15

        
          

        

      

      
         

      

    

     

    ARTICLE
      V

    Sublicensing
      and Service Agreements by Licensee

    

    5.1 License
      and Service Agreements.
      Licensee shall enter into only such forms of license and service agreements
      which adequately protect the Intellectual Property Rights connected with the
      Licensed Materials and which provide the same equivalent protection for such
      rights as is provided for Licensee’s similar Intellectual Property Rights in its
      own proprietary information.

    

    5.2 Terms
      of Sublicense and Service Agreements.
      Any
      form of sublicense or service agreement used by Licensee for transactions that
      involve the Licensed Materials:

    

    
      	 	
              5.2.1

            	
              With
                United States government departments or agencies shall include a
                restricted-rights clause conforming to the Federal Acquisition Regulations
                then in effect that protects the intellectual rights and ownership
                of the
                Licensed Materials.

            

    

    

    
      	 	
              5.2.2

            	
              Shall
                include an exclusion of incidental, consequential, special, punitive,
                or
                exemplary damage remedies against Licensee and
                Licensor.

            

    

    

    
      	 	
              5.2.3

            	
              Shall
                contain appropriate confidentiality agreements in a similar form
                as
                Licensee uses to protect its own proprietary
                information.

            

    

    

    

    ARTICLE
      VI

    Warranties
      of Licensor

    

    Licensor
      warrants and represents to Licensee that:

    

    6.1 Infringement.
      To the
      best of its knowledge, Licensor’s grant of the License and the use of the
      Licensed Materials by Licensee pursuant to this Agreement will not infringe
      any
      valid and subsisting Intellectual Property Right of any person other than
      Licensee or an affiliate of Licensee. No other person is using or has access
      to
      the Licensed Materials for the Permitted Purposes.

    

    6.2 Accuracy
      of Information.
      To the
      best of Licensor’s knowledge, all information contained in the Licensed
      Materials is accurate and not misleading. Licensor further warrants that, upon
      learning of any inaccuracy in or in completeness of any Licensed Material,
      Licensor promptly will notify Licensee of such matter and take all actions
      necessary to make the Licensed Materials complete and accurate or pay the
      actual, reasonable costs incurred by Licensee in correcting any such Licensed
      Materials.

     

    
      
         

      

      
        6
          of
          15

        
          

        

      

      
         

      

    

     

    6.3 Disclaimer
      of All Other Warranties and Representations.
      The
      express warranties and representation set forth in this Article VI are in lieu
      of, and LICENSOR DISCLAIMS, ANY AND ALL OTHER WARRANTIES, CONDITIONS, OR
      REPRESENTATIONS (EXPRESS OR IMPLIED, ORAL OR WRITTEN) WITH RESPECT TO THE
      IMPLIED WARRANTIES OR CONDITIONS OF TITLE, NON-INFRINGEMENT, MERCHANTABILITY,
      OR
      FITNESS OR SUITABILITY FOR ANY PURPOSE (WHETHER OR NOT LICENSOR KNOWS, HAS
      REASON TO KNOW, HAS BEEN ADVISED, OR IS OTHERWISE IN FACT AWARE OF ANY SUCH
      PURPOSE), WHETHER ALLEGED TO ARISE BY LAW, BY REASON OF CUSTOM OR USAGE IN
      THE
      TRADE, OR BY COURSE OF DEALING. IN ADDITION, LICENSOR EXPRESSLY DISCLAIMS ANY
      WARRANTY OR REPRESENTATION TO ANY PERSON OTHER THAN LICENSEE WITH RESPECT TO
      THE
      LICENSED SOFTWARE OF ANY PART THEREOF.

    

    

    ARTICLE
      VII

    Licensor’s
      Infringement-Defense Obligation

    

    7.1 Covenant
      to Defend.
      As a
      covenant separate from its non-infringement representation, Licensor, at its
      own
      expense, shall defend claims against Licensee by third parties that any use
      of
      the Licensed Materials, consistent with this Agreement, constitutes an
      infringement of an Intellectual Property Right under any applicable law.

    

    7.2 Conditions
      for Licensor Defense.
      To be
      entitled to a defense by Licensor against any such third-party infringement
      claim:

    

    
      	 	
              7.2.1

            	
              Licensee
                shall advise Licensor of the existence of the claim by the most
                expeditious reasonable means immediately upon learning of the assertion
                of
                the claim against Licensee (whether or not litigation or any other
                proceeding has been filed or served);
                and

            

    

    

    
      	 	
              7.2.2

            	
              Licensee
                shall permit Licensor to have the sole right to control the defense
                and/or
                settlement of all such claims, so long as no such settlement adversely
                affects Licensee’s ability to exercise the License
                Rights.

            

    

    

    7.3 Actions
      Upon Injunctive Relief.
      In the
      event a preliminary injunction or other injunctive relief is entered that
      materially enjoins Licensee from exercising the License, Licensee may suspend
      payment of all monies owing to Licensor until such time, if any, as the
      preliminary injunction is vacated or stayed. For so long as such injunction
      is
      in effect, the consideration described in Section 3.1 above shall be abated.
      

    

    7.4 Actions
      Upon Successful Assertion of Infringement Claim.
      If a
      third-party infringement claim is sustained in a final judgment from which
      no
      further appeal is taken or possible, and Licensor is not able to procure, at
      its
      sole cost, for Licensee the right to continue to use the Licensed Materials
      pursuant to this Agreement, this Agreement shall terminate.

     

    
      
         

      

      
        7
          of
          15

        
          

        

      

      
         

      

    

     

    ARTICLE
      VIII

    Indemnity
      and Defense Obligations

    

    8.1 Mutual
      Indemnity.
      Each
      party (the “Defending
      Party”)
      shall
      defend, hold harmless the other party (the “Protected
      Party”)
      against any and all claims, losses, liabilities, costs and damages
      (collectively, the “Claims”)
      arising from or relating to any material inaccuracy in any representation,
      and
      any material breach of any warranty or covenant under this
      Agreement.

    

    8.2 Defense
      Procedure.
      Each
      Protected Party seeking to be defended against a claim under this Agreement
      shall notify the Defending Party within sixty (60) days of the assertion of
      any
      Claim(s) or discovery of any fact upon which the Protected Party intends to
      base
      a claim for defense and /or indemnification under this Agreement. The Protected
      Party’s failure to so notify a Defending Party shall relieve the Defending Party
      from any liability under this Agreement to the Protected Party with respect
      to
      defense or indemnity with respect to such Claim(s).

    

    8.3 Participation
      in and Control of Defense.
      If a
      Defending Party defends a Protected Party in a lawsuit, arbitration,
      negotiation, or other proceeding (“dispute”) concerning a Claim pursuant to this
      Agreement, the Protected Party shall have the right to engage separate counsel,
      at the Protected Party’s expense, to monitor and advise the Protected Party
      about the status and progress of the defense.

    

    
      	 	
              8.3.1

            	
              With
                respect to any issue involved in such dispute as to which the Defending
                Party has acknowledged the obligation to indemnify the Protected
                Party,
                the Defending Party shall have the sole right to control the defense
                of
                (and/or settle or otherwise dispose of) the dispute on such terms
                as the
                Defending Party in its judgment deems
                appropriate

            

    

    

    
      	 	
              8.3.2

            	
              To
                be entitled to sole control of the defense, upon request by the Protected
                Party, the Defending Party shall demonstrate to the reasonable
                satisfaction of the Protected Party the Defending Party’s financial
                ability to carry out its defense obligations (and its indemnity
                obligations if any).

            

    

    

    8.4 Offset
      of Indemnity Amounts.
      In any
      event requiring indemnity of one party by another hereunder, the indemnitee
      may
      offset, against any payments subsequently due to the indemnitor from the
      indemnitee, any amount remaining unpaid under this indemnitee unless otherwise
      provided in this Agreement.

    

    8.5 No
      Defense or Indemnity for Own Negligence or Misconduct.
      Except
      as may be expressly provided otherwise in this Agreement, no party shall be
      required to defend or indemnify any other party with respect to Claims finally
      adjudged to have been caused by the putative indemnitor’s own negligence, gross
      negligence, or willful misconduct (i.e., misconduct in bad faith). Reasonable
      expenses incurred by a Protected Party who is or is threatened to be made a
      named defendant or respondent in a dispute may be paid or reimbursed by the
      Defending Party, in advance of the final disposition of the proceeding, after
      the Defending Party receives a written undertaking by or on behalf of the
      Protected Party to repay the amount paid or reimbursed, if and to the extent
      it
      is ultimately determined that the Protected Party was negligent or grossly
      negligent or had engaged in willful misconduct.

     

    
      
         

      

      
        8
          of
          15

        
          

        

      

      
         

      

    

     

    ARTICLE
      IX

    Confidential
      Information

    

    9.1 Definition.
      As used
      herein, the term “Confidential
      Information”
means
      the Licensed Materials and any other information that is proprietary to a party
      or has been acquired or is being used by such party pursuant to a
      confidentiality agreement with a third party and which is not generally known
      in
      the relevant industry or industry segment and affords possessors of the
      information a commercial or business advantage over others who do not have
      such
      information.

    

    9.2 Illustrative
      Types of Confidential Information.
      The
      term “Confidential
      Information”
may
      include, but is not limited to, customer information, accounting data,
      statistical data, research projects, development and marketing plans, customer
      lists, and insurance payor data.

    

    9.3 Exclusions
      from Confidential Information Status.
      The
      term “Confidential
      Information”
does
      not include any information that, through no fault of the receiving party,
      is or
      becomes:

    

    
      	 	
              9.3.1

            	
              Substantially
                described in an English language printed
                publication;

            

    

    

    
      	 	
              9.3.2

            	
              Developed
                by or on behalf of the receiving party;
                or

            

    

    

    
      	 	
              9.3.3

            	
              Disclosed
                to the receiving party by a third party not having an obligation
                of
                confidence to the owner of such
                Information.

            

    

    

    9.4 Security
      Conditions.
      Confidential Information shall be maintained under secure conditions by a
      receiving party using at least the same security procedures used by such
      receiving party for the protection of its own Confidential Information.

    

    9.5 Non-Use
      Obligation.
      The
      receiving party shall not use any Confidential Information, except for the
      benefit of such Information, without the express prior written consent of an
      authorized officer of the owner of such Information during the term of this
      Agreement and for three years thereafter and shall not disclose any such
      information without such consent except as permitted by this Agreement or
      except:

    

    
      	 	
              9.5.1

            	
              To
                those of the receiving party’s employees and the performance of such
                receiving party’s obligations under this
                Agreement;

            

    

     

    
      
         

      

      
        9
          of
          15

        
          

        

      

      
         

      

    

     

    
      	 	
              9.5.2

            	
              To
                third parties who execute confidentiality agreement acknowledging
                the
                obligations of confidentiality under this
                Agreement;

            

    

    

    
      	 	
              9.5.3

            	
              To
                those Authorized Licensee Delegates who have executed an appropriate
                form
                of binding non-disclosure agreement or are otherwise obligated to
                preserve
                the receiving party’s confidences;
                or

            

    

    

    
      	 	
              9.5.4

            	
              Upon
                the order of a court or other tribunal of competent jurisdiction
                to
                disclose such Confidential Information, upon notice to the owner
                of such
                Information.

            

    

    

    9.6 Third-Party
      Misappropriation.
      A
      receiving party of Confidential Information shall immediately report to the
      owner of such Information any attempt by any person of which the receiving
      party
      has knowledge to use or disclose Confidential Information without authorization
      from its owner.

    

    9.7  Post-Termination
      Procedures.
      Upon
      any termination of the receiving party’s right to possess and/or use
      Confidential Information, the receiving party shall turn over to the owner
      of
      the Confidential Information (or, if agreed by such owner, destroy) any disks,
      tapes, documentation, notes, memorandum, documents, or any other tangible
      embodiments of any such Information.

    

    

    ARTICLE
      X

    Arbitration

    

    10.1 All
      disputes arising out of or relating to the subject matter of this Agreement
      shall be arbitrated in accordance with the Commercial Arbitration Rules of
      the
      American Arbitration Association by a single arbitrator chosen by each party
      and
      a single arbitrator agreed to by both parties. If no such agreement of the
      jointly chosen arbitrator is obtained, then an arbitrator will be appointed
      by
      the American Arbitration Association. Each party to such arbitration shall
      have
      the disclosure responsibilities mandated by Rule 26(a) of the Federal Rules
      of
      Civil Procedure. Discovery shall be governed by Rules 26 through 36 of the
      Federal Rules of Civil Procedure, except as to any limitations on scope or
      amount agreed to by the parties or imposed in his sole discretion by the
      arbitrator. Actions for injunctive relief or any violation of the
      confidentiality prohibitions of Article IX may be sought in a court of competent
      jurisdiction without initial reference to arbitration pursuant to this Article.
      The arbitrator shall have the power to include punitive damages or incidental
      or
      consequential damages in the arbitration award and the arbitrator shall have
      the
      power to award attorneys’ fees to the prevailing party. Judgment on the
      arbitration award in accordance with this Agreement may be entered in any state
      or federal court of competent jurisdiction.

    

    
      
         

      

      
        10
          of
          15

        
          

        

      

      
         

      

    

     

    ARTICLE
      XI

    General
      Provisions

    

    11.1 Entire
      Agreement.
      Except
      as may be expressly provided otherwise herein, this Agreement constitutes the
      entire agreement between the parties concerning the subject matter thereof.
      No
      prior or contemporaneous representations, inducements, promises, or agreements,
      oral or otherwise, between the parties with reference thereto shall be of any
      force or effect. No modification or amendment to this Agreement shall be valid
      or binding unless reduced to writing and duly executed by the party or parties
      to be bound thereby.

    

    11.2 Authority
      and Other General Warranties.
      Each
      party warrants to the other that:

    

    
      	 	
              11.2.1

            	
              The
                execution and/or performance of this Agreement does not and will
                not
                violate or interfere with any other agreement of it, which violation
                or
                interference would have a material adverse effect on
                it;

            

    

    

    
      	 	
              11.2.2

            	
              It
                will not enter into any agreement the execution and/or performance
                of
                which would violate or interfere with this Agreement and have a material
                adverse effect on the other party;

            

    

    

    
      	 	
              11.2.3

            	
              It
                is not presently the subject of, nor the proponent of, any claim
                that
                would have a material adverse effect on the other
                party.

            

    

    

    11.3 Survival
      of Representations and Warranties.
      The
      representations and warranties made herein shall survive the execution of this
      Agreement and the termination of the License except as may be expressly
      indicated otherwise.

    

    11.4 Independent
      Parties.
      The
      parties are independent contractors. Except as may be expressly and
      unambiguously provided in this Agreement, no partnership or joint venture is
      intended to be created by this Agreement, nor any principal-agent or
      employer-employee relationship.

    

    
      	 	
              11.4.1

            	
              Except
                to the extent expressly provided in this Agreement neither party
                has, and
                neither party shall, attempt to assert, the authority to make commitments
                for or to bind the other party to any
                obligation.

            

    

    

    
      	 	
              11.4.2

            	
              Although
                this Agreement contains covenants with respect to Confidential
                Information, the parties disclaim any other intent to create a
                confidential or fiduciary relationship between
                them.

            

    

    

    11.5 Injunctive
      Relief.
      Each
      party acknowledges that any violation by that party of its covenants in this
      Agreement relating to Intellectual Property Rights would result in damage to
      the
      other party that is largely intangible but nonetheless real, and that is
      incapable of complete remedy by an award of damages. Accordingly, any such
      violation shall give the other party the right to a court-ordered injunction
      or
      other appropriate order to specifically enforce those covenants.

     

    
      
         

      

      
        11
          of
          15

        
          

        

      

      
         

      

    

     

    11.6 Survival
      of Restrictive Covenants.
      The
      covenants herein concerning Intellectual Property Rights shall be construed
      as
      independent of any other provision hereof. The existence of any claim or cause
      of action by a party, whether predicated on this Agreement or otherwise, shall
      not constitute a defense to enforcement by the other party of such
      covenants.

    

    11.7 Effect
      of Partial Invalidity.
      If any
      one or more of the provisions of this Agreement should be ruled wholly or partly
      invalid or unenforceable by a court or other government body of competent
      jurisdiction, then:

    

    
      	 	
              11.7.1

            	
              The
                validity and enforceability of all provisions of this Agreement not
                ruled
                to be invalid or unenforceable shall be
                unaffected;

            

    

    

    
      	 	
              11.7.2

            	
              The
                provision(s) held wholly or partly invalid or unenforceable shall
                be
                deemed amended, and the court or other government body is authorized
                to
                reform the provision(s), to the minimum extent necessary to render
                them
                valid and enforceable in conformity with the parties’ intent as manifested
                herein; and

            

    

    

    
      	 	
              11.7.3

            	
              If
                the ruling, and/or the controlling principle of law or equity leading
                to
                the ruling, is subsequently overruled, modified, or amended by
                legislative, judicial, or administrative action, then the provision(s)
                in
                question as originally set forth in this Agreement shall be deemed
                valid
                and enforceable to the maximum extent permitted by the new controlling
                principle of law or equity.

            

    

    

    11.8 Assignment.
      No
      party may assign any right under this Agreement, and any purported assignment
      shall be null and void and a breach of this Agreement, except for the following
      or as otherwise provided herein:

    

    
      	 	
              11.8.1

            	
              Either
                party may assign this Agreement with the express prior written consent
                of
                the other party.

            

    

    

    
      	 	
              11.8.2

            	
              Any
                party may assign all of its rights indivisibly to an entity in which
                a
                party owns more than 50% of the voting interests or which owns more
                than
                50% of the voting interests of a party, and which agrees in writing
                to
                comply with the party’s obligations under, and to be bound by, this
                Agreement.

            

    

    

    
      	 	
              11.8.3

            	
              Either
                party may assign all of its rights indivisibly (but not divisibly)
                in
                connection with a sale or other disposition of substantially all
                the
                assets of that party’s business relating to the Licensed Materials to a
                single acquiring entity. The acquiring entity must agree in writing
                to
                comply with the assigning party’s obligations under, and to be bound by,
                this Agreement.

            

    

     

    
      
         

      

      
        12
          of
          15

        
          

        

      

      
         

      

    

     

    11.9 Notices.
      Any
      notices provided or required under the terms of this Agreement shall be
      effective immediately when provided by verified facsimile transmission or
      personal delivery one business day after being deposited with a nationally
      recognized overnight courier, or five days after being sent by first class
      mail,
      and addressed as follows:

    

     

    If
      to
      LICENSOR:

    

    Lumonall
      Canada Inc.

    _________________________

    

    _________________________

    

    With
      a
      copy to:

    

    If
      to
      LICENSEE:

    

    Midland
      International Corp. 

    12650
      Jane Street

    King
      City, Ontario, Canada L7B 1A3

    

    With
      a
      copy to:

    

    Andrew
      I.
      Telsey, Esq.

    Andrew
      I.
      Telsey, P.C.

    12835
      E.
      Arapahoe Road

    Tower
      1
      Penthouse #803

    Englewood,
      CO 80112

    

    11.10 Remedies.
      Except
      as otherwise provided herein or in this Agreement, the remedies set forth herein
      or in this Agreement are not exclusive, and either party shall be entitled
      alternatively or cumulatively to damages for breach of this Agreement or to
      any
      other remedy available under applicable law.

    

    11.11 Choice
      of Law.
      This
      Agreement shall be interpreted and enforced in accordance with the law of the
      Province of Ontario, Canada applicable to agreements made and performed entirely
      in the Province of Ontario, Canada by persons domiciled therein.

    

    11.12 Attorney’s
      Fees.
      If
      litigation or other action is commenced between the parties concerning any
      dispute arising out of or relating to this Agreement, the prevailing party
      shall
      be entitled, in addition to any other award that may be made, to recover all
      court costs or other official costs and all reasonable expenses associated
      with
      the action, including without limitation reasonable attorney’s fees and
      expenses.

     

    
      
         

      

      
        13
          of
          15

        
          

        

      

      
         

      

    

     

    11.13 No
      Waiver.
      The
      failure of either party at any time to require performance by the other party
      of
      any provision of this Agreement shall in no way affect the right of such party
      to require performance of that provision. Any waiver by either party of any
      breach of any provision of this Agreement shall not be construed as a waiver
      of
      any continuing or succeeding breach of such provision, a waiver of the provision
      itself or a waiver of any right under this Agreement.

    

    11.14 Binding
      on Successors.
      This
      Agreement shall be binding upon and inure to the benefit of the Parties and
      their successors and assigns permitted by this Agreement.

    

    11.15 Article
      Headings.
      The
      article headings contained in this Agreement are for reference purposes only
      and
      shall not in any way control the meaning or interpretation of this
      Agreement.

    

    11.16 Representation
      of Counsel; Mutual Negotiation.
      Each
      party has been and had the opportunity to be represented by counsel of its
      choice in negotiating this Agreement. This Agreement shall therefore be deemed
      to have been negotiated and prepared at the joint request, direction, and
      construction of the parties, at arms length, with the advice and participation
      of counsel, and shall be interpreted in accordance with its terms without favor
      to any party.

    

    11.17 Counterparts;
      Facsimile Execution.
      This
      Agreement may be executed in separate counterparts, each of which so executed
      and delivered shall constitute an original, but all such counterparts shall
      together constitute one and the same instrument. Each person signing below
      represent that (s)he has read this Agreement in its entirety, understands its
      terms, and on behalf of the party indicated below by his or her name agrees
      that
      such party shall be bound by those terms. For purposes of this Agreement, a
      document (or signature page thereto) signed and transmitted by facsimile machine
      or telecopier is to be treated as an original document. The signature of any
      party thereon, for purposes hereof, is to be considered as an original
      signature, and the document transmitted is to be considered to have the same
      binding effect as an original signature on an original document. At the request
      of any party, a facsimile or telecopy document is to be re-executed in original
      form by the parties who executed the facsimile or telecopy document. No party
      may raise the use of a facsimile machine or telecopier machine as a defense
      to
      the enforcement of the Agreement or any amendment or other document executed
      in
      compliance with this Section.

    

    

    (balance
      of page intentionally left blank - signature page
      follows)

     

    
      
         

      

      
        14
          of
          15

        
          

        

      

      
         

      

    

    
 

    IN
      WITNESS WHEREOF the parties hereto have executed this Agreement effective as
      of
      the date first written above.

     

     

    
 

    
      	
              LICENSOR:

               

              LUMONALL CANADA INC.

               

               

               

              
                By:                                                                           

                

                Title:                                                                        

                

                Date:                                                                        

              

            	
              LICENSEE:

               

              MIDLAND INTERNATIONAL CORPORATION

               

               

              
                By:                                                                           

                

                Title:                                                                        

                

                Date:                                                                        

              

            

    

    

         

    
      
         

      

      
        15
          of
          15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}]]